Chemotherapy for gastrointestinal cancer and non-small cell lung cancer: A controversial issue;Chemotherapie gastrointestinaler karzinome und nicht-kleinzelliger lungenkarzinome: Eine kontroverse

Schweizerische Medizinische Wochenschrift

Volumn 126, Issue 20, 1996, Pages 872-878

  Fey, M F ^a   Sauter, Chr ^b   Alberto, P ^c  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOCETAXEL; GEMCITABINE; IRINOTECAN; PACLITAXEL; TOPOTECAN;

CANCER CHEMOTHERAPY; DIGESTIVE SYSTEM CANCER; GOOD CLINICAL PRACTICE; HUMAN; LUNG CANCER; MEDICAL DECISION MAKING; MEDICAL RESEARCH; PATIENT CARE; SHORT SURVEY;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; COLONIC NEOPLASMS; GASTROINTESTINAL NEOPLASMS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PALLIATIVE CARE;

EID: 0029938514     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Herrmann R: Systemic treatment of colorectal cancer. Eur J Cancer 1994; 30A: 404-409.
2. Safi F, Bittner R, Roscher R: Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy): Results of a controlled clinical trial. Cancer 1989; 64: 379-387.
3. Patt YZ: Editorial: Regional hepatic arterial chemotherapy for colorectal cancer metastatic to the liver: The controversy continues. J Clin Oncol 1993; 11: 815-819.
4. Hohn DC, Stagg RJ, Friedman MA: A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group Trial. J Clin Oncol 1989; 7: 1646-1654.
5. Chang AE, Schneider PD, Sugarbaker PH: A prospective randomized trial of regional versus systemic continuous 5-Fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987; 206: 685-693.
6. Kirk Martin J, O'Connell MJ, Wieand HS: Intra-arterial Floxuridine vs systemic Fluorouracil for hepatic metastases from colorectal cancer. Arch Surg 1990; 125: 1022-1027.
7. Kemeny N, Lokich JJ, Anderson N, Ahlgren JD: Recent advances in the treatment of advanced colo-rectal cancer. Cancer 1993; 71: 9-18.
8. Rougier P, Laplanche A, Huguier M: Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomized trial. J Clin Oncol 1992; 7: 1112-1118.
9. Kemeny N, Daly J, Reichman B: Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma: A randomized trial. Ann Intern Med 1987; 107: 459-465.
10. Kemeny N, Seiter K, Conti JA: Hepatic arterial Floxuridine and Leucovorin for unresectable liver metastases from colorectal carcinoma: New dose schedules and survival update. Cancer 1994; 73: 1134-1142.
11. Moertel C: Chemotherapy for colorectal cancer. N Engl J Med 1994; 330: 1136-1142.
12. Hafström L, Engaras B, Holmberg SB: Treatment of liver metastases from colorectal cancer with hepatic artery occlusion, intraportal 5-Fluorouracil infusion, and oral allopurinol: A randomized clinical trial. Cancer 1994; 74: 2749-2756.
13. Buchegger F, Vacca A, Carrel S, Schreyer M, Mach JP: Radioimmunotherapy of human colon carcinoma by 131 J labeled monoclonal antibodies in a nude mouse model. Internat J Cancer 1988; 41: 127-134.
14. e Coll Méd Nucl Langue Française, 1995.
15. Glimelius B, Hoffmann K, Graf W: Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer. Cancer 1994; 73: 556-562.
16. Grilli R, Oxman AD, Julian JA: Chemotherapy for advanced non-small-cell lung cancer: How much benefit is enough? J Clin Oncol 1993; 11: 1866-1872.
17. Ganz PA, Figlin RA, Haskell CM: Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer: Does chemotherapy make a difference? Cancer 1989; 63: 1271-1278.
18. Rapp E, Pater JL, Willan A: Chemotherapy can prolong survival in patients with advanced non-small cell lung cancer - report of a Canadian multicenter randomized trial. J Clin Oncol 1988; 6: 633-641.
19. Cellerino R, Tummarello D, Guidi F: A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small cell lung cancer. J Clin Oncol 1991; 9: 1453-1461.
20. Souquet PJ, Chauvin F, Boissel JP: Polychemotherapy in advanced non small cell lung cancer: A meta-analysis. Lancet 1993; 342: 19-21.
21. Sauter C: Ist eine palliative Chemotherapie beim nicht-kleinzelligen Bronchuskarzinom sinnvoll? Schweiz Med Wochenschr 1995; 125: 1500.
22. Ihde DC: Chemotherapy of lung cancer. New Engl J Med 1992; 327: 1434-1441.
23. Joss RA, Bürki K, Dalquen P: Combination chemotherapy with Mitomycin, Vindesine, and Cisplatin for non-small cancer: Association of antitumour activity with initial tumour burden and treatment center. Cancer 1990; 65: 2426-2434.
24. Egger T, Cerny T: Chemotherapy der Lungenkarzinome. Ther Umschau 1994; 4: 267-271.
25. Smith TJ, Hillner BE, Desch CE: Efficacy and cost-effectiveness of cancer treatment: Rational allocation of resources based on decision analysis. J Nat Cancer Insitute 1993; 85: 1460-1474.
26. Comis RL, Friedland DM: New chemotherapy agents in the treatment of advanced non-small cell lung cancer: An update including data from the 7th World Conference on Lung Cancer. Lung Cancer 1995; 12 (Suppl. 2): 63-99.